SCHEMBL19035944

SCHEMBL19035944

c1ccc2c(c1)Sc1cccc3c4ccccc4n-2c13

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 11/20 0.44
▸ MAOA P21397 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ACHE P22303 4/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.38
▸ SLC6A3 Q01959 2/20 0.38
▸ NOX1 Q9Y5S8 1/20 0.38
▸ ALKBH5 Q6P6C2 1/20 0.38
▸ FTO Q9C0B1 1/20 0.38
▸ DUSP3 P51452 1/20 0.37
▸ GRIN1 Q05586 1/20 0.36
▸ GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29767396 1.00 BCHE (0.44) BCHEMAOAKDM4EATML3MBTL1
SCHEMBL18534090 0.88 L3MBTL1 (0.40) BCHEMAOAKDM4EATML3MBTL1
SCHEMBL30643546 0.86 BCHE (0.43) BCHEMAOAACHEALDH1A1SLC6A3
SCHEMBL29087114 0.86 BCHE (0.43) BCHEMAOAACHEALDH1A1SLC6A3
SCHEMBL30643545 0.86 BCHE (0.43) BCHEMAOAACHEALDH1A1SLC6A3
SCHEMBL20976182 0.85 BCHE (0.39) BCHEMAOAL3MBTL1ACHEHPGD
SCHEMBL24537219 0.83 KDM4E (0.39) BCHEMAOAKDM4EATML3MBTL1
SCHEMBL24536989 0.83 L3MBTL1 (0.39) BCHEMAOAKDM4EATML3MBTL1
SCHEMBL24537239 0.83 KDM4E (0.39) BCHEMAOAKDM4EATML3MBTL1
SCHEMBL24537398 0.82 NPSR1 (0.44) BCHEKDM4EL3MBTL1ACHEHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11649249-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2023-05-16 — — US disclosed
US-20200395548-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PERFORMANCE MATERIALS GERMANY GMBH (DE) 2020-12-17 — — US disclosed
US-10336772-B2 Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-02 — — US disclosed
US-20170183360-A1 BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-29 — — US disclosed
US-20170183360-A1 BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336772-B2 Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound BRD1, CYP1B1, ARL1 BCHE 1303/4885MAOA 1550/4885KDM4E 4064/4885
US-11649249-B2 Compounds for electronic devices DDT, CYP2C9, CYP2D6 BCHE 361/4885MAOA 103/4885KDM4E 2128/4885
US-20170183360-A1 BICARBAZOLE COMPOUND, MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING BICARBAZOLE COMPOUND BRD1, CYP1B1, ARL1 BCHE 1303/4885MAOA 1550/4885KDM4E 4064/4885
US-20200395548-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES TRMT1, EED, TEC BCHE 2530/4885MAOA 978/4885KDM4E 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback